-
Syndax Closes Public Offering
Post on 12/13/20
-
Forma Therapeutics Prices of Public Offering
Post on 12/11/20
-
Solid Biosciences Announces $90 Million Private Placement
Post on 12/11/20
-
Biogen: Don't Give Up On This High Yielder
Post on 12/11/20
-
Is Moderna Stock a Good Bet on Coronavirus Vaccines?
Post on 12/11/20
-
How Much Money Will Moderna Make From Its COVID Vaccine?
Post on 12/11/20
-
Forget Moderna! These 2 Stocks May be the Biggest Winners of the Vaccine Race
Post on 12/11/20
-
What Could Keep the FDA From Green Lighting Pfizer's and Moderna's Vaccines?
Post on 12/11/20
-
Repligen Corp. Closes Public Offering of $312.2M
Post on 12/10/20
-
Blue Cross Blue Shield of Massachusetts Awarded AIM's 2020 Sustainability Award
Post on 12/10/20
-
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results
Post on 12/10/20
-
Cities That Need the Most Initial Vaccinations Against COVID-19 – WalletHub Study
Post on 12/10/20
-
Faze Medicines Launches With $81 Million Series A
Post on 12/10/20
-
Here's What Could Make Moderna's COVID Vaccine a Bigger Winner Than Pfizer's
Post on 12/10/20
-
After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?
Post on 12/10/20
-
Is Biogen Getting Desperate?
Post on 12/10/20
-
Moderna Stock: Buy at the High?
Post on 12/10/20
-
Is Moderna Stock a Hold?
Post on 12/10/20
-
Nym Ranked Among Top 10 Most Promising Startups of 2020
Post on 12/9/20
-
EyePoint Pharmaceuticals Announces 1-for-10 Reverse Stock Split
Post on 12/9/20
-
Sigilon Therapeutics Closes of Upsized IPO
Post on 12/9/20
-
Thermo Fisher Doubles Global Footprint For Drug Development And Commercial Manufacturing
Post on 12/9/20
-
iSpecimen Seeks $20 Million In U.S. IPO Plan
Post on 12/9/20
-
Curis Announces Proposed Public Offering of Common Stock
Post on 12/8/20
-
Forma Therapeutics Launches Proposed Public Offering
Post on 12/8/20